Superior and effective microbiome therapeutics

About us

CHAIN Biotechnology Ltd is a microbiome therapeutics company with a novel drug development platform targeting chronic gut-related diseases.

Platform

Our Clostridium Assisted Drug Development (CADD™) platform provides superior gut delivery to support a pipeline of drug candidates addressing multiple therapeutic areas associated with the gut microbiome.

Clinical Focus

We target inflammatory bowel disease with a focus on Ulcerative Colitis. Our lead drug candidate is a live biotherapeutic engineered to produce anti-inflammatory metabolites; β-hydroxybutyrate and butyrate.